Lu Zy

1.1k total citations
12 papers, 912 citations indexed

About

Lu Zy is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lu Zy has authored 12 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Lu Zy's work include Multiple Myeloma Research and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Lu Zy is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Lu Zy collaborates with scholars based in France and China. Lu Zy's co-authors include Bernard Klein, Régis Bataille, J Brochier, JF Rossi, Tim N. Beck, Bart Barlogie, R Bataille, Thierry Lavabre‐Bertrand, XG Zhang and John Wijdenes and has published in prestigious journals such as Blood, Bone Marrow Transplantation and PubMed.

In The Last Decade

Lu Zy

12 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu Zy France	7	543	459	390	220	94	12	912
JF Rossi France	13	461 0.8×	473 1.0×	292 0.7×	319 1.4×	99 1.1×	22	927
R Bataille France	9	371 0.7×	372 0.8×	282 0.7×	219 1.0×	52 0.6×	13	707
M Charon France	13	515 0.9×	224 0.5×	309 0.8×	184 0.8×	191 2.0×	20	906
Firas Muwalla United States	11	1.2k 2.2×	556 1.2×	970 2.5×	93 0.4×	190 2.0×	13	1.4k
F. Dreyfus France	15	645 1.2×	441 1.0×	462 1.2×	256 1.2×	326 3.5×	56	1.2k
J. Graham Sharp United States	12	255 0.5×	250 0.5×	181 0.5×	113 0.5×	96 1.0×	26	633
C. Vasselon France	11	420 0.8×	273 0.6×	625 1.6×	127 0.6×	139 1.5×	27	964
Maria Daniotti Italy	10	323 0.6×	335 0.7×	607 1.6×	150 0.7×	88 0.9×	11	1.2k
Timothy J. Ernst United States	7	188 0.3×	286 0.6×	494 1.3×	248 1.1×	152 1.6×	8	955

Countries citing papers authored by Lu Zy

Since Specialization

Citations

This map shows the geographic impact of Lu Zy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Zy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Zy more than expected).

Fields of papers citing papers by Lu Zy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Zy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Zy. The network helps show where Lu Zy may publish in the future.

Co-authorship network of co-authors of Lu Zy

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Zy. A scholar is included among the top collaborators of Lu Zy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Zy. Lu Zy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Xu, Ning, et al.. (2016). [Clinical characteristics and prognosis of 35 patients with therapy-related hematological neoplasms].. PubMed. 37(3). 221–6. 1 indexed citations

2.

Zhang, Yangyang, et al.. (2011). [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].. PubMed. 46(12). 892–7. 1 indexed citations

3.

Mohty, Mohamad, Nathalie Fegueux, Lu Zy, et al.. (2001). Enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy. Bone Marrow Transplantation. 28(4). 335–339. 31 indexed citations

4.

Zy, Lu, et al.. (2001). [A research on the correlation of oral mucosal patches stria diseases and epithelial dysplasia].. PubMed. 10(2). 102–4. 2 indexed citations

5.

Zy, Lu, et al.. (1997). [Effects of tachykinin receptor antagonists on allergic asthma in guinea pigs].. PubMed. 32(5). 326–30. 1 indexed citations

6.

Zy, Lu, et al.. (1996). [Cultural perspectives of health and illness in the context of nursing].. PubMed. 43(4). 42–8. 8 indexed citations

7.

Bataille, R, Bart Barlogie, Lu Zy, et al.. (1995). Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood. 86(2). 685–691. 207 indexed citations

8.

Klein, Bernard, et al.. (1995). Interleukin-6 in human multiple myeloma. Blood. 85(4). 863–872. 453 indexed citations

9.

Zy, Lu, XG Zhang, Carmen Rodríguez, et al.. (1995). Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood. 85(9). 2521–2527. 81 indexed citations

10.

Liautard, Jean‐Pierre, Félix A. Montero‐Julian, Christophe Duperray, et al.. (1994). Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies.. PubMed. 5(3). 293–300. 16 indexed citations

11.

Klein, Bernard, XG Zhang, M Jourdan, et al.. (1991). Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.. PubMed. 1(4). 193–201. 109 indexed citations

12.

Yan, Zhongzheng, et al.. (1990). [Detection of circulating antigen in schistosomiasis by dot-ELISA with monoclonal antibody].. PubMed. 8(3). 161–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact